BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 11245449)

  • 21. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
    Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
    Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
    Dreij K; Seidel A; Jernström B
    Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer.
    Kennedy DO; Agrawal M; Shen J; Terry MB; Zhang FF; Senie RT; Motykiewicz G; Santella RM
    J Natl Cancer Inst; 2005 Jan; 97(2):127-32. PubMed ID: 15657342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells.
    Chiang HC; Tsou TC
    Toxicol In Vitro; 2009 Aug; 23(5):897-905. PubMed ID: 19470404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
    Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of (7S,8R)-dihydroxy-(9R,10S)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene adducts in human serum albumin by laser-induced fluorescence: implications for the in vivo metabolism of benzo[a]pyrene.
    Ozbal CC; Skipper PL; Yu MC; London SJ; Dasari RR; Tannenbaum SR
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):733-9. PubMed ID: 10919745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological monitoring of fire fighters: sister chromatid exchange and polycyclic aromatic hydrocarbon-DNA adducts in peripheral blood cells.
    Liou SH; Jacobson-Kram D; Poirier MC; Nguyen D; Strickland PT; Tockman MS
    Cancer Res; 1989 Sep; 49(17):4929-35. PubMed ID: 2503247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
    Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
    Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of benzo[a]pyrene-DNA adducts from leukocytes from heavy smokers.
    Arnould JP; Hermant A; Levi-Valensi P; Belegaud J
    Pathol Biol (Paris); 1998 Dec; 46(10):787-90. PubMed ID: 9922995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiles and genetic damage in benzo(a)pyrene diol epoxide-exposed TK6 cells.
    Akerman GS; Rosenzweig BA; Domon OE; McGarrity LJ; Blankenship LR; Tsai CA; Culp SJ; MacGregor JT; Sistare FD; Chen JJ; Morris SM
    Mutat Res; 2004 May; 549(1-2):43-64. PubMed ID: 15120962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer.
    Gu J; Horikawa Y; Chen M; Dinney CP; Wu X
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2445-50. PubMed ID: 18768515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk.
    Zhu Y; Spitz MR; Zheng YL; Hong WK; Wu X
    Cancer; 2002 Aug; 95(3):563-8. PubMed ID: 12209748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of benzo(a)pyrene diol epoxide-DNA adducts in mononuclear white blood cells by CE immunoassay and its application to studying the effect of glutathione depletion.
    LeBlanc A; Shen S; Lew K; Weinfeld M; Le XC
    Electrophoresis; 2009 May; 30(9):1558-63. PubMed ID: 19343725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.
    Wu X; Gu J; Patt Y; Hassan M; Spitz MR; Beasley RP; Hwang LY
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):567-70. PubMed ID: 9681523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
    Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
    Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts.
    Beland FA; Churchwell MI; Von Tungeln LS; Chen S; Fu PP; Culp SJ; Schoket B; Gyorffy E; Minárovits J; Poirier MC; Bowman ED; Weston A; Doerge DR
    Chem Res Toxicol; 2005 Aug; 18(8):1306-15. PubMed ID: 16097804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide.
    Pastorelli R; Guanci M; Cerri A; Negri E; La Vecchia C; Fumagalli F; Mezzetti M; Cappelli R; Panigalli T; Fanelli R; Airoldi L
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):703-9. PubMed ID: 9718223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
    Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ
    Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation of diastereomeric benzo[a]pyrene diol epoxide-guanine adducts in p53 gene-derived DNA sequences.
    Matter B; Wang G; Jones R; Tretyakova N
    Chem Res Toxicol; 2004 Jun; 17(6):731-41. PubMed ID: 15206894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.